Abdelnaby, R.M.; El-Malah, A.A.; FakhrEldeen, R.R.; Saeed, M.M.; Nadeem, R.I.; Younis, N.S.; Abdel-Rahman, H.M.; El-Dydamony, N.M.
In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers. Pharmaceuticals 2022, 15, 700.
https://doi.org/10.3390/ph15060700
AMA Style
Abdelnaby RM, El-Malah AA, FakhrEldeen RR, Saeed MM, Nadeem RI, Younis NS, Abdel-Rahman HM, El-Dydamony NM.
In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers. Pharmaceuticals. 2022; 15(6):700.
https://doi.org/10.3390/ph15060700
Chicago/Turabian Style
Abdelnaby, Rana M., Afaf A. El-Malah, Rasha R. FakhrEldeen, Marwa M. Saeed, Rania I. Nadeem, Nancy S. Younis, Hanaa M. Abdel-Rahman, and Nehad M. El-Dydamony.
2022. "In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers" Pharmaceuticals 15, no. 6: 700.
https://doi.org/10.3390/ph15060700
APA Style
Abdelnaby, R. M., El-Malah, A. A., FakhrEldeen, R. R., Saeed, M. M., Nadeem, R. I., Younis, N. S., Abdel-Rahman, H. M., & El-Dydamony, N. M.
(2022). In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers. Pharmaceuticals, 15(6), 700.
https://doi.org/10.3390/ph15060700
